| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671535 | Clinical Microbiology and Infection | 2017 | 20 Pages |
Abstract
Empirical NSBM appears to be effective in the majority of hospitalized immunocompetent adults with non-severe CAP and should be further evaluated in randomized trials.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
S. Rhedin, I. Galanis, F. Granath, A. Ternhag, J. Hedlund, C. Spindler, P. Naucler,